XJQ

N-[(3,4-dichlorophenyl)methyl]-2-[4-oxo-6-(4-{[(3S)-oxolan-3-yl]methyl}piperazin-1-yl)quinazolin-3(4H)-yl]acetamide

Created:	2023-06-07
Last modified:	2024-12-18

Find Related PDB Entry
1 entries where XJQ is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	65
Chiral Atom Count	1
Bond Count	69
Aromatic Bond Count	12

2D diagram of XJQ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(3,4-dichlorophenyl)methyl]-2-[4-oxo-6-(4-{[(3S)-oxolan-3-yl]methyl}piperazin-1-yl)quinazolin-3(4H)-yl]acetamide
Systematic Name (OpenEye OEToolkits)	~{N}-[(3,4-dichlorophenyl)methyl]-2-[4-oxidanylidene-6-[4-[[(3~{R})-oxolan-3-yl]methyl]piperazin-1-yl]quinazolin-3-yl]ethanamide
Formula	C₂₆ H₂₉ Cl₂ N₅ O₃
Molecular Weight	530.446
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Clc1ccc(cc1Cl)CNC(=O)CN1C=Nc2ccc(cc2C1=O)N1CCN(CC2CCOC2)CC1
SMILES	CACTVS	3.385	Clc1ccc(CNC(=O)CN2C=Nc3ccc(cc3C2=O)N4CCN(CC4)C[CH]5CCOC5)cc1Cl
SMILES	OpenEye OEToolkits	2.0.7	c1cc(c(cc1CNC(=O)CN2C=Nc3ccc(cc3C2=O)N4CCN(CC4)CC5CCOC5)Cl)Cl
Canonical SMILES	CACTVS	3.385	Clc1ccc(CNC(=O)CN2C=Nc3ccc(cc3C2=O)N4CCN(CC4)C[C@H]5CCOC5)cc1Cl
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc(c(cc1CNC(=O)CN2C=Nc3ccc(cc3C2=O)N4CCN(CC4)C[C@H]5CCOC5)Cl)Cl
InChI	InChI	1.06	InChI=1S/C26H29Cl2N5O3/c27-22-3-1-18(11-23(22)28)13-29-25(34)15-33-17-30-24-4-2-20(12-21(24)26(33)35)32-8-6-31(7-9-32)14-19-5-10-36-16-19/h1-4,11-12,17,19H,5-10,13-16H2,(H,29,34)/t19-/m0/s1
InChIKey	InChI	1.06	ZFFSYULCWWRFBM-IBGZPJMESA-N

Related Resource References

Resource Name	Reference
PubChem	172635972

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.